{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifylrth3g2ew65imdmoneipxoitwjnbapgdezdqn4cbrzmhtidwae",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mgqr3iocvn72"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreid3sq7meogdlkimyqrg7oxzt4jbyo3lbvjt742yzs6vs66b3uozje"
    },
    "mimeType": "image/jpeg",
    "size": 59109
  },
  "path": "/pharmalot/2026/03/10/novo-failed-report-side-effects-fda-wegovy-ozempic/?utm_campaign=rss",
  "publishedAt": "2026-03-10T14:51:35.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Breaking News",
    "Pharmalot",
    "FDA",
    "legal",
    "Pharmaceuticals",
    "side effects",
    "STAT+"
  ],
  "textContent": "It's the third time in recent weeks that the FDA has admonished Novo Nordisk for different practices.",
  "title": "STAT+: Novo Nordisk is warned by the FDA for failing to report potential side effects tied to GLP-1 drugs",
  "updatedAt": "2026-03-10T21:20:22.000Z"
}